The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study
- PMID: 34134526
- PMCID: PMC8212025
- DOI: 10.1177/03331024211020404
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study
Abstract
Objective: To investigate the association of headache during the acute phase of SARS-CoV-2 infection with long-term post-COVID headache and other post-COVID symptoms in hospitalised survivors.
Methods: A case-control study including patients hospitalised during the first wave of the pandemic in Spain was conducted. Patients reporting headache as a symptom during the acute phase and age- and sex-matched patients without headache during the acute phase participated. Hospitalisation and clinical data were collected from medical records. Patients were scheduled for a telephone interview 7 months after hospital discharge. Participants were asked about a list of post-COVID symptoms and were also invited to report any additional symptom they might have. Anxiety/depressive symptoms and sleep quality were assessed with the Hospital Anxiety and Depression Scale and the Pittsburgh Sleep Quality Index.
Results: Overall, 205 patients reporting headache and 410 patients without headache at hospitalisation were assessed 7.3 months (Standard Deviation 0.6) after hospital discharge. Patients with headache at onset presented a higher number of post-COVID symptoms (Incident Rate Ratio: 1.16, 95% CI: 1.03-1.30). Headache at onset was associated with a previous history of migraine (Odd Ratio: 2.90, 95% Confidence Interval: 1.41-5.98) and with the development of persistent tension-type like headache as a new post-COVID symptom (Odd Ratio: 2.65, 95% CI: 1.66-4.24). Fatigue as a long-term symptom was also more prevalent in patients with headache at onset (Odd Ratio: 1.55, 95% CI: 1.07-2.24). No between-group differences in the prevalence of anxiety/depressive symptoms or sleep quality were seen.
Conclusion: Headache in the acute phase of SARS-CoV-2 infection was associated with higher prevalence of headache and fatigue as long-term post-COVID symptoms. Monitoring headache during the acute phase could help to identify patients at risk of developing long-term post-COVID symptoms, including post-COVID headache.
Keywords: COVID-19; anxiety; depression; fatigue; headache; post-COVID; sleep.
Conflict of interest statement
Figures
Similar articles
-
Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study.Front Hum Neurosci. 2021 Jun 28;15:678472. doi: 10.3389/fnhum.2021.678472. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34295230 Free PMC article.
-
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.J Neurol Sci. 2022 Mar 15;434:120162. doi: 10.1016/j.jns.2022.120162. Epub 2022 Jan 29. J Neurol Sci. 2022. PMID: 35121209 Free PMC article. Review.
-
Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.JAMA Netw Open. 2021 Nov 1;4(11):e2134803. doi: 10.1001/jamanetworkopen.2021.34803. JAMA Netw Open. 2021. PMID: 34783824 Free PMC article.
-
Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study.Int J Clin Pract. 2021 Dec;75(12):e14917. doi: 10.1111/ijcp.14917. Epub 2021 Sep 29. Int J Clin Pract. 2021. PMID: 34569684 Free PMC article.
-
Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.Rev Neurol. 2021 Jun 1;72(11):384-396. doi: 10.33588/rn.7211.2021230. Rev Neurol. 2021. PMID: 34042167 Review. English, Spanish.
Cited by
-
Altered metabolites in the periaqueductal gray of COVID-19 patients experiencing headaches: a longitudinal MRS study.Front Neurol. 2024 Jan 5;14:1323290. doi: 10.3389/fneur.2023.1323290. eCollection 2023. Front Neurol. 2024. PMID: 38249726 Free PMC article.
-
New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.BMC Infect Dis. 2023 Dec 14;23(1):877. doi: 10.1186/s12879-023-08898-2. BMC Infect Dis. 2023. PMID: 38097988 Free PMC article.
-
TCM "medicine and food homology" in the management of post-COVID disorders.Front Immunol. 2023 Aug 31;14:1234307. doi: 10.3389/fimmu.2023.1234307. eCollection 2023. Front Immunol. 2023. PMID: 37720220 Free PMC article. Review.
-
Incidence of post-COVID-19 syndrome and its association with COVID-19 severity in a tertiary private hospital: Prospective cohort study.IJID Reg. 2023 Aug 13;9:14-17. doi: 10.1016/j.ijregi.2023.08.005. eCollection 2023 Dec. IJID Reg. 2023. PMID: 37719715 Free PMC article.
-
Treatment of COVID-19 Vaccine Resistant Migraine Attack with CGRP Monoclonal Antibody: A Case Report.Noro Psikiyatr Ars. 2023 Aug 12;60(3):292-294. doi: 10.29399/npa.28266. eCollection 2023. Noro Psikiyatr Ars. 2023. PMID: 37645079 Free PMC article.
References
-
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
